PEABODY, Mass., April 1, 2010 (GLOBE NEWSWIRE) — Analogic Corporation (Nasdaq:ALOG), a leading provider of medical imaging and aviation security technology, announced today that it has received an order from L-3 Communications Security and Detection Systems, Inc. for EXplosive Assessment Computed Tomography (EXACT®) systems valued at approximately $9.7 million. The TSA-certified eXaminer 3DX®, developed by Analogic and L-3 Communications, incorporates the EXACT subsystem. This new order is expected to start shipping in the third quarter of fiscal 2010.
Peter Cempellin, vice president and general manager of Analogic’s Security Systems Division, said, “As expected, this new order from L-3 indicates that we are returning to a more stable run rate. Throughout our long-standing relationship, Analogic and L-3 have been making ongoing improvements to the eXaminer 3DX to maintain its well-earned reputation for excellent field performance and reliability.”
More than 900 eXaminer 3DX systems are installed in airports around the world, screening checked baggage. The system features advanced, multi-slice CT imaging technology and provides full 3-D images of all the contents of a bag, enabling automatic detection of explosives. Analogic and L-3 also provide the government-certified eXaminer SX and eXaminer XLB systems, which address various throughput needs of smaller and very large airports.
Analogic is a high-technology company that designs and manufactures advanced medical imaging and security systems and subsystems sold to original equipment manufacturers (OEMs) and end users in the healthcare and homeland security markets. We are recognized worldwide for advancing state-of-the-art technology in the areas of computed tomography (CT), magnetic resonance imaging (MRI), digital radiography, specialized ultrasound, and automatic explosives detection for airport security. Our OEM customers incorporate our technology into systems that they in turn sell for various medical and security applications. We also sell our ultrasound products directly to specialized clinical end-user markets through our direct worldwide sales force under the business name BK Medical ApS (BK Medical). For more information, visit www.analogic.com.
CONTACT: Analogic Corporation Mark Namaroff, Director of Strategic Marketing and Investor Relations (978) 326-4058 Investorrelations@analogic.com
(C) Copyright 2010 GlobeNewswire, Inc. All rights reserved.